Abstract-Cheese whey is a by-product
I. INTRODUCTION
Cheese whey is the major by-product stream, generated during cheese or casein production process. Cheese whey is of relative high importance for the industrial dairy sector, attributed mainly to 1) its high organic load that makes management cost prohibitive, especially for the medium sized cheesemaking industries 2) its high nutritional value (owning to its functional ingredients).
The current total worldwide production of whey is estimated at about 180 to 190 million tons/year. Of that, 40×10 6 tons/year of whey are produced in the European Union. Approximately 70% of whey is converted, by the implementation of processes, into different products, and still approximately the rest 30% of whey is being utilized either for animal feeding, or as fertilizer or even dumped into the rivers or the sea (Koller et During industrial cheese-making process, only 10% of the initial raw milk is bio-converted to cheese, while the rest 90% represents cheese whey. More specifically, it has been estimated that for every 1-2 kg of produced cheese, 8-9 kg of whey are generated. That means that for every 100 kg of milk used to produce different types of cheese, 9.3 ± 0.7 kg of fresh cheese and approximately 90.7 kg of both sweet or acid whey are generated (Baldasso et al., 2011) . Besides, considering that cheese whey's organic load is high (expressed by high values of COD (60-80 g/L) and BOD5 (varied from 35.000 to 55.000 mg O2/L) its disposal into the environment could erase severe environmental issues (Koutinas et al., 2009 ). In fact, when this thin watery by-product stream is discharged into water bodies, reduces the dissolved oxygen, impeding biodegradability, while erasing major threats to both aquatic organisms as well as environment, putting at risk human health and welfare. Additionally, when cheese whey is disposed of to the land, provokes serious environmental issues, by changing the physicochemical characteristics of cultivated surrounding soil, lowering cultivated crops productivity (Ghaly et al., 2007) . Biological treatment of whey is a rather difficult management option, owning mainly to its acidic pH (3.8 -6.5), low alkalinity and sodium, free ammonia, potassium and volatile fatty acid contents. Therefore, proper treatment or re-usage of cheese whey before its disposal is required. So, revalorization of cheese whey to value added products such as functional or bioceutical ingredients could offer a sustainable waste management option, promoting circular economy, while protecting human health.
Generally, there are two possible routes for integrating cheese whey to value added products. The first one entails direct process, referring either to physical or thermal treatment of whey. The outcome of these processes is the transformation of cheese whey to several functional value-added fractions such as whey powder, whey protein concentrate, whey protein isolate, whey-permeate and lactose (Nagar et al., 2013) . The second possible revalorization route is oriented toward the implementatio n of proper bioprocessing systems, using cheese whey as raw material for the production of functional foods or bio-based ingredients. In this case, cheese whey is used, as raw material for various microbial or enzymatic bioconversions, leading to the production of several valueadded products such as bio-protein (single cell protein-SCP), enzymes, carotenoids or biopigments, biopreservatives, biological gums, exo-polysaccharides, microbial oil, and bio-plastics (Dimou et Atra et al., 2004) . Demand for whey-based products such as whey protein concentrates, reduced lactose whey, whey protein and hydrolyzed whey is growing, due to their high functional and nutritional properties (Gupta et al., 2012) . Moreover, biotransformation of whey permeate into protein-rich biomass, galacto-oligosaccharides and carotenoids seems to be other options of whey valorization to functional products with increased industrial interest.
Single cell protein production, using whey as raw material could be carried out by the proper implementatio n of suitable bioprocessing systems by lactose-consuming yeasts (such as Kluyveromyces sp. and Candida sp.) and bacteria (such as Lactobacillus sp.) bioconversions (Sawin et al., 2015; Panesar et al., 2013; Spălăţelu et al., 2012) . The produced bio-protein could be used as animal feed or as protein enrichment agent leading to the production of novel rich in protein-functional foods. Also, it should be noted that whey derived proteins hold the highest nutritional quality (Protein Digestibility-Corrected Amino Acid Score=1) among dietary protein sources, while simultaneously have greater biological value than milk protein casein. Besides, most bio-whey based products contain all the spectrum of amino acids including not only the human-essential amino acids but also a large variety of branched chain and sulfur-containing amino acids, which promote metabolic regulation and protein folding (Smithers et al., 2015) . Cheese whey-based products (owning to their rich content of bioactive compounds such as protein, lactose, minerals, enzymes and glycomacropeptides) may provide antimicrobial activity, immune modulation, improved muscle strength and body composition, while protecting from the development of cardiovascular diseases and osteoporosis (Smithers et al., 2015; Gupta et al., 2012) Indeed, cheese whey bio-proteins may also possess several in-vivo biological functions with positive effects on digestive, endocrine and nervous system (Gupta et al., 2012; Sawin et al., 2015) . However, designing and implementing novel bioderived processing systems leading to the production of carotenoids, using cheese whey as raw material is of high academic interest, aiming at substituting chemical synthesized counterparts. Possible bio-carotenoid production using cheap substrates such as cheese whey, could satisfy the trend towards natural food coloring, not to mention that carotenoids, as functional ingredients fulfill a variety of biological and physiological roles in living organisms, ranging from light harvesting in photosynthesis to protection against light and oxidizing agents . Valorization of agroindustrial products toward the production of valueadded products of industrial food interest is a current and emerging trend, opening new roads toward the production of novel functional foods of high nutritional value (Dimo u et al. This paper highlights potential valorization routes of cheese whey to value added products of high nutritional value and industrial food interest such as bioproteins and carotenoids. However, beneficial health promoting effects of cheese whey derived products (bioactive peptides or bioproteins) are discussed.
II. CHEES E WHEY AN UNEXPLOITED VALUABLE FEEDSTOCK FOR THE PRODUCTION OF VALUE-ADDED FUNCTIONAL PRODUCTS
Cheese whey is the main liquid watery by product stream generated after the precipitation and removal of milk casein throughout cheese manufacturing process, using milk as raw material. Approximately 33% of the worldwide milk production is used in cheese manufacturing process, yielding about 19x10 6 tones cheese whey per year (Blaskó et al., 2012) . A general flowchart of cheese production process, highlighting cheese whey formulation (after the coagulation of milk caseins), as a byproduct stream of cheese processing is presented in Figure- 1. Until recently, sweet whey has been discarded or used as animal feed, without further exploited towards the production of valuable functional ingredients. Recovering the solid components of whey is attractive for two main reasons: 1) for reducing organic pollution caused when cheese whey waste streams are dis posed of in open areas and 2) for recovering from whey, value added products of high nutritional value as well as functional properties.
Figure-1: Flowchart highlighting cheese whey production during cheese making process
Regarding cheese whey physical characteristics; color of whey varies from a dominantly yellow/green to rarely a bluish tinge. As logical, color is strongly influenced by the type of milk used for cheese making . Whey is produced from all types of milk. In Europe, the most usual type of milk used is cow's milk. Also, other types of milk are used for the production of cheese such as goat's, sheep's and camel's milk (Bordenave-Juchereau et al., 2005). It is worth-noting, that the final nutritional value and composition of resulting whey is highly associated with the initial type of milk used for the production of each type of cheese.
Both traditional and modern cheese manufacturing processes, lead to the production of huge watery effluents, which corresponds to approximately 90% of the initial volume of milk used for cheese making. Whey retains more than 55% (w/v) of the bio-compounds contained in the initial milk used as the main raw material for cheese making production process. Cheese whey contains approximately: lactose (4.5-5 % w/v); soluble proteins (0.6-0.8% w/v); lipids (0.4-0.5 w/v) and mineral salts (8-10 w/v, of dried extract) (Nagar et al., 2013) . So, this effluent could be regarded as a valuable matrix rather than a waste product stream that could find several potential applications in food, health and pharmaceutical sector.
III. POTENTIAL INTEGRATION OF CHEES E
WHEY TO VALUE ADDED PRODUCTS Processing of cheese whey, owning to its residual milk constituents, could lead to the production of several value-added products of high commercial value. Nowadays, almost the 50% of the total produced cheese whey, world-widely, is revalorized into different functional and nutritional value-added products, with increased industrial interest. Of these commercialized food products, the 45% are in liquid form, 30% are different types of dried whey powder, 15% is lactose and the remaining fraction consist of by-product streams remained during the production of whey protein concentrates (Panesar et al., 2013; Kossea et al., 2009; Carvalho et al., 2013) . Nowadays, several functional whey-based products are produced, using cheese whey as raw material, employing proper developed bioprocesses and physicochemical techniques. The most significant commercially available functional cheese whey-based products are: whey powder, whey concentrate, whey protein isolate, single cell protein, exo-polysaccharides and bio-carotenoids. In fact, physicochemical processes could lead to the production of protein rich whey products such as: 1) whey powder, 2) whey permeate fractions, and 3) concentrated whey proteins. Physicochemical treatment of cheese whey includes the implementation of processing steps such as precipitation with coagulants or thermal/isoelectric precipitation and membrane separation (for instance ultrafiltration, reverse osmosis, ultrafiltratio n etc.) (Prazeres et al., 2012) . More specifically, whey powder could be produced directly from cheese whey ( Figure-1 ). Cheese whey is first pasteurized and then dried. Finishing drying process, a fine white powder, called whey powder is produced (Kargi et al., 2006) . Whey concentrate streams are typically filtered (using more frequently ultrafiltration and reverse osmosis), so as to filter cheese or concentrate whey components based on the pore size of the membrane and the molecular weight of the whey filtered components. Through passing the semi-permeable membrane, cheese whey's lactose and salts (smaller particles) are removed, yielding concentrates of different protein contents. Throughout the aforementioned process leading to protein concentrated, two streams are generated: whey permeate containing mainly lactose and salts and a whey protein isolate fraction (Nasseri et al., 2011) . Whey protein isolate in fact is a proteinaceous rich whey-based functional product containing more than 90 % proteins. These functional value-added products could be further exploited by a large variety of processes. Of them, the most usual are microfiltration and ion exchange. Via microfiltration additional fat and lactose are removed so as to facilitate up to 90% (increased) protein concentration in the final whey protein product. Advanced chromatography techniques may then be implemented so as to fractionate individual function protein isolates such as lactoferrin, lactoperixidase (from the main whey proteins: α-lactalbumin, β-lactoglobulin and bovine serum albumin ) and glycomacropeptide (Neville et al., 2006; Barile et al. 2009 ) which are functional ingredients of high nutritional value. Also, several functional products such as peptides, oligosaccharides, single cell protein and carotenoids could be produced, through the implementation of proper bioconversion systems, using cheese whey or cheese permeate as cheap raw material (Table-1 ). However, several times prior to bioconversions lactose hydrolysis should take place, so as to enhance whey usefulness and product yields, when microorganisms are unable to utilize it. Lactose hydrolysis to monosaccharaides (glucose and galactose) could either be catalyzed enzymatically, using β-galactosidase or by acid hydrolysis treatment (AguirreEzkauriatza et al., 2010). Hydrolyzed lactose from whey permeate could be used as a substrate for the production of exopolysaccharides -E.P.S by fermentation. Xanthan gum (a heteropolysaccharide) could be produced by a number of microorganisms such as Xanthomonas sp though the development of proper bioprocessing systems. Xanthan gum find several applications in the production of food products (bakery, prepared foods, and beverages) and drug formulations in tablets and suspensions, owning to its unique rheological properties, such as highly pseudoplastic behavior (which contributes to its wide-range applications as suspending, stabilizing, thickening and emulsifying agent for food and pharmaceutical applications) (Regenhardt et al., 2013) . Hydrolyzed lactose from whey permeate could be used as a substrate for the production of exopolysaccharides -E.P.S by fermentation. Xanthan gum (a heteropolysaccharide) could be produced by a number of microorganisms such as Xanthomonas sp though the development of proper bioprocessing systems. Xanthan gum find several applications in the production of food products (bakery, prepared foods, and beverages) and drug formulations in tablets and suspensions, owning to its unique rheological properties, such as highly pseudo-plastic behavior (which contributes to its wide-range applications as suspending, stabilizing, thickening and emulsifying agent for food and pharmaceutical applications) (Regenhardt et al., 2013) . It has been also reported that whey lactose is also used to produce dextrans (through Leuconostoc sp, Streptococcus sp, Rhizobium sp bioconversions), and biopolymers (such as poly-β-hydroxy butyrate) ( ). Furthermore, since the larger molecular weight dextrans can act as osmotic agents, these biomolecules could be used to treat hypovolemia. Also, a cyclic oligosaccharide derived from dextran, cyclodextrin , could be used as cariostatic, anti-HIV and anti-ulcer agent (De Vuyst et al., 2001 ). It should be stressed out that E.P.S finds several applications in industrial food and pharmaceutical sector as gelling, thickening and stabilizing agents. Bio-products such as xanthan gum and dextran, commonly used in food processing sector, have been approved by F.D.A to be used as food additives (Ramalingam et al., 2014) . In the last years, EPS's prebiotic role has been identified and described. Apart EPS role as prebiotics, Lactobacillus sp synthesized EPS have been reported to have several health promoting beneficial effects, acting as anti-tumor, immune-stimulator and blood cholesterol lowering agents (Zannini et al., 2013). Potential carotenoid production (β-carotene, torulene), using microbial strains such as Rhodotorula glutinis and cheese whey as raw material, has been reported (Koutelidakis et al., 2019). Humans are unable to biosynthesize carotenoids, and therefore, they must be supplied with diet. Owning to their antioxidant activity, carotenoids protect the skin against the UV light. Furthermore, they strengthen the immune system and accelerate wound healing. Some carotenoids constitute vitamin A precursors, and thus may be protective in eye disease. So, bio-carotenoids hold a great potential to be used as fortifying vitamin "carrier" for the production of nutrient supplements and functional food, preventing and in some cases decreasing the severity of hypovitaminosis-A. Bio-carotenoids are used in food production as food pigments or coloring agents, substituting their chemical synthesized counterparts. Recently, the increasing consumer awareness on the negative effect of synthetic pigments on human health has increased interest in natural pigments. The use of microorganisms as "bioreactors" for the production of carotenoids might serve human health leading to the production of "healthy bio-carotenoids" substituting their chemical synthesized counterparts . Microbiological synthesis of different types of carotenoids, using cheese whey as raw material, is of high interest and more research should be carried out.
IV.
WHEY PROTEINS: PROPERTIES AND FUNCTIONALITY Lately, there is a current trend in separating out (concentrate) proteinaceous functional products from cheese whey using sophisticated downstream processes. The common in vitro bottom-up proteomics include the following steps: 1) isolation of proteins or a protein mixture from a food matrix, such as cheese whey, 2) hydrolysis of proteins by different enzymatic proteases. The most common enzymes used are: (a) pepsin, trypsin and chymotrypsin (gastrointestinal enzymes), (b) alcalase, bromelain and ficin, proteases originated fro m microorganisms or plants, (c) enzymes present in cheese making bioprocessing, by starter Lactobacillus or nonstarter Lactobacillus (3) fractionation, separation, isolation and purification of functional peptides or proteins, (4) bioactivity tests, (5) identification of interesting bioactive peptides (Agyei et al., 2016) .
Whey protein consists of several different proteins, including β-lactoglobulin (β-LG), α-lactalbumin (α-LA), the heavy-and light-chain immunoglobulins (Igs), bovine serum albumin (BSA), lactoferrin (LF), lactoperoxidase (LP), and glycomacropeptide (GMP). Whey protein may also contain protease-peptone components and lowmolecular-weight products formed during enzymatic casein degradation throughout cheese making process (Madureira et al., 2007) . The average individual proteins' concentration in cheese as well as their characteristics is depicted in "Table-2".
Compared to various vegetable proteins sources, whey protein has all the essential amino acids in higher concentrations. It contains all 20 amino acids and all nine essential amino acids. Because of its content of essential amino acids, the biological value of whey protein is high compared to other dietary proteins (Madureira et al., 2007) . β-Lactoglobulin (β-LG) is one of the most important whey proteins, accounting for approximately either 64% of the heat-coagulable proteins or 51% of the total whey proteins. Its molecular weight varies from 18.20 to 18.36 kDa. Generally, it is consisted of 2 identical subunits, as a dimer. In fact, each monomer consists of one sulfhydryl group and two disulfide bonds. The number of amino acids in the single peptide chain of β-LG is 162. Whey protein isolate is a functional proteinaceous product which in fact is whey isolate enriched with β-LG. It should be noted that enriched with β-LG whey protein isolate products demonstrate enhanced functional properties (such as emulsion stability, activity, viscosity and gelling properties) compared to cheese whey concentrate (Hernández-Ledesma et al., 2011, Madureira et al., 2007) . Results of work on β-LG gelation indicated that it may demonstrate gel strength as much as three times greater than that of egg white protein at the same protein concentration. This suggested that β-LG fraction was capable of replacing egg white in the manufacture of processed meat and fish products (Rantamaki et al., 2010) .
The bovine serum albumin (BSA) component of whey is a large globular protein with a good essential amino acid profile. More specifically, the number of amino acids in BSA is 582. Whey protein contains approximately 5-6% bovine serum albumin, which is almost suchlike to that included to human milk. The molecular mass of BSA is 66.26 kDa. BSA molecule is consisted of 35 cysteine residues and 17 disulfide linkages. The nature of BSA is very heterogeneous and in fact its content in milk is approximately the same included in bovine blood (Modler et al., 2009) . One important feature of BSA is that it could be used as a carrier of fatty acids, owning to its capacity to bind reversibly to several ligands (Markus et al., 2002) . Furthermore α-LA and α-LA -peptides could be used as food supplements of essential amino acids demonstrating several beneficial effects either by improving immun e system, reducing the stress, enhancing opioid activity or by demonstrating antihypertensive action, as well as by provoking regulation of cell growth (Matsumoto et al., 2001 ). Furthermore, cheese whey α-La, owning to its high content of amino acids (such as cysteine), promote wound healing, while boosting the immune system, preventing the development of chronic diseases. So, utilization of α-La, as enrichment agent or bioceutical for the production of infant formulas is of high academic interest. Regarding the positive health effects of milk or cheese whey α-La are numerous. It has been revealed that α-La have potential anti-proliferative effects in human adenocarcinoma cell lines such as Caco-2 and HT-29 (Brück et al., 2014) . It is well known that human α-lactalbumin and oleic acid (HAMLET), is the first member in a new family of proteinlipid complexes. These complexes were first isolated fro m human milk. Hamlet may act as a potent anticancer agent, killing tumor cells with high selectivity. Protein-lipid complexes impart tumoricidal properties on a broad basis, targeting novel treatments by identifying death pathways (Brück et al., 2014) . BAMLET, which in fact is the bovine milk a-lactalbumin counterpart of HAMLET, remainin g also in cheese whey derived from bovine milk cheese making process, triggers in cancer cells a pathway for lysosomal cell death; therefore, alpha-lactalbumin: oleate complexes can kill tumor cells that are highly resistant to apoptosis (Ho et al., 2012; Rammer et al., 2013) .
Immunoglobulins (Igs) constitute a complex group of protein molecules. In fact, Ig is an antibody or gamma globulin. It seems that the whey fraction of milk contains Igs, corresponding approximately to 10-15% of total whey proteins. The Igs in whey have demonstrated antimicrobial activity and a great potential to neutralize toxins and viruses. It has been revealed that raw milk from nonimmunized cows contains specific antibodies to Escherichia coli, Salmonella enteritidis, Salmonella typhimurium and human rotavirus Yolken et al., 1985) .
Bioactive components derived from whey fractions, such as Igs, GMP (Glycomacropeptide) and whey-derived minerals have demonstrated specific health benefits, such as enhanced immune function and antioxidant activity, relief of metabolic stress, positive stress responses, improved muscle functionality and greater strength (Philanto-Leppala. 2001). Controlled clinical studies have shown that the oral administration of immune milk preparations containing specific antibodies may have therapeutic value against gastrointestinal infections in humans (Gupta et al., 2017) .
Lactoperoxidase (LP) is the most abundant enzyme in whey. Its molecular mass is 78 kDa and in fact is a single polypeptide chain of 612 amino acid residues. It contains 15 cysteines, one heme group and about 10% w/w of carbohydrate moieties (Modler, 2009 ). It accounts for 0.25-0.50% of total protein found in whey. Actually, LP could possibly act protectively against infectious microbes (Gupta et al., 2017; Shin et al., 2005) . Glycomacropeptide (GMP) is a caseinomacropeptide (CMP), formed during cheese makin g process from milk k-casein component through the action of the milk-clotting enzyme (e.g. chymosin). The GMP's amino acid residue is 64. Also, its MW and isoelectric pH is equal to 6.8 kDa and varied from 4.3 to 4.6, accordingly (Rajput et al., 2013) . GMP molecules have unique attributes owning to the absence of aromatic amino acids (more specifically phenylalanine, tryptophan, tyrosine, histidine, arginine or cysteine) (Philanto-Leppala, 2001). Thus, this glycomacropeptite, if properly isolated fro m cheese whey could be used as dietary ingredient for the formulation of products suitable for patients who suffer from phenylketonuria (since glycomacropeptide is free of phenylalanine). Phenylketonuria is an inborn error of amino acid (AA) metabolism. This is caused by deficient activity of the enzyme phenylalanine hydroxylase. Phenylalanine hydroxylase is needed to convert the essential AA phenylalanine to tyrosine (Acosta et al., 2010; Baldasso et al., 2011) . So, in that case the development of a suitable nutritional program in the form of low-phenylalanine diet, enriching it with GMP functional products, could help patients achieve metabolic control of phenylalanine levels (Rajput, 2013) . By the proper free phenylalanine diet, those who suffer of inborn phenylketonuria could normally allow the development of their brain. Indeed, since GMP, is a bioactive peptide whose unique composition and characteristics may offer health-promoting effects, forms a potential ingredient for various functional foods and pharmaceuticals.
V.
WHEY PROTEINS: PROPERTIES AND FUNCTIONALITY Nowadays, it is well known that whey proteins have several functional properties and are characterized by high nutritional value. The functional properties of cheese whey are mainly attributed to physical, chemical and structural characteristics of cheese whey's individual proteins content. Regarding the nutritional value of cheese whey, it should be noted that it is highly associated with the concentration of contained (depending on cheese whey type and milk origin) essential amino acids (especially sulfur-containing ones) as well as branched-chain amino acids (isoleucine, leucine and valine) (Acosta et al., 2010) . Moreover, whey proteins are generally recognized as GRAS for food applications. So, cheese whey could find several applications in the production of several functional, rich in whey, food products such as healthy foods, dairy foods, meat products, frozen foods and baby food formulations (Baldasso et al., 2011) . Also, it has been reported that whey proteins are already used in bakery, confectionary, meats and seafood leading to the formation of a strong gel with high water-holding capacity ( . It has been demonstrated that tryptic peptides through the regulation of tumor necrosis factor-a and interferon-g production, in a concanavalin A-induced hepatitis model, prevent the increase of plasma aspartate aminotransferase and alanine aminotransferase (Kume et al., 2006) . Besides, whey proteins and peptides have shown a hepatoprotective effect in a d-galactosamine-induced hepatitis model, through their preventing action against the increase of plasma levels of hepatic function markers, including bilirubin , alanine aminotransferase aspartate aminotransferase and lactate, dehydrogenase (Salehi et al., 2012) . Also, it has been reported that early enteral nutrition with this enriched with cheese whey immune-regulating formula is able of preventing post-transplant bacteremia and hyperglycemia without increasing the potential development of acute cellular rejection in patients (Kaido et al., 2012) . The anticancer effects of whey have been instigated by the conduction of animal studies. Cheese whey's anticancer potential has been mainly attributed to the antioxidizin g , detoxifying, and immune-enhancing effects of lactoferrin. Mice performed studies revealed that, in lactoferrin presence, colon cancer demonstrated reduced tumor expression while cancer metastasis was inhibited (Sekine et al., 1997) . Cheese whey could be regarded as an ideal optional source of protein and peptides, owning to its enhanced absorption in the intestines especially for those who suffer from compromised gastrointestinal function, for instance ileostomy patients. It is possible that patients who suffer from cancer, undergoing chemotherapy may benefit from this feature of whey, since anti-cancer therapies influence nutrient intake and absorption (Shariatikia et al., 2017) . Besides, the positive effects of milk products in lowering blood pressure and reducing the risk of hypertension have been revealed. An 8-week trial, in which 20 healthy men were administrated by a combination of fermented milk and whey protein concentrate, demonstrated comparatively higher highdensity lipoproteins, lower triglycerides and lower systolic blood pressure (Kawase et al., 2000) . Besides, the positive effects of milk products in lowering blood pressure and reducing the risk of hypertension have been revealed. An 8-week trial, in which 20 healthy men were administrated by a combination of fermented milk and whey protein concentrate, demonstrated comparatively higher highdensity lipoproteins, lower triglycerides and lower systolic blood pressure (Kawase et al., 2000) . Also, it has been claimed that certain bioactive peptides, formed throughout the hydrolysis of food proteins, inhibit angiotensin converting enzyme (ACE), acting positively in reducing blood pressure (Korhonen et al., 2007) .
VI.
CONCLUSION Valorization of CW to functional ingredients (such as whey proteins, individual peptides, cheese whey concentrates, cheese whey hydrolysates, oligosaccharides, single cell protein and bio-carotenoids) could offer an alternative ecological and sustainable option of addressing waste management issues, promoting circular economy and human health, preventing or sometimes acting therapeutically against the development of diseases including the chronic ones, while providing market with a wide spectrum of functional and health promoting value added products.
